Delobel Pierre, Sandres-Sauné Karine, Cazabat Michelle, L'Faqihi Fatima-Ezzahra, Aquilina Christian, Obadia Martine, Pasquier Christophe, Marchou Bruno, Massip Patrice, Izopet Jacques
Laboratory of Virology EA2046-IFR30, Toulouse University Hospital, France.
AIDS. 2005 Nov 4;19(16):1739-50. doi: 10.1097/01.aids.0000183125.93958.26.
Reservoirs of HIV-1 are a major obstacle to virus eradication. There is therefore a need to clearly understand the molecular nature of the virus populations that persist in patients with sustained suppression of plasma viraemia on highly active antiretroviral therapy (HAART).
We performed a detailed analysis of the genotypes of HIV-1 quasispecies isolated from highly purified blood cell types taken from three selected patients with sustained undetectable viral loads on HAART for 7 years.
We used polychromatic flow cytometry to sort naive and memory CD4 T cells, CD14 monocytes, and CD56+CD3- natural killer (NK) cells from the total peripheral blood mononuclear cells after 7 years of HAART. Clonal analysis was used to determine coreceptor use and drug-resistance genotypes of HIV-1 quasispecies in the sorted blood cell types.
We detected HIV-1 DNA in memory and naive CD4 T cells and in CD14 monocytes, but not in the CD56+CD3- NK cells. Phylogenetic analysis demonstrated that the various blood cells types of two of the three patients harboured genetically distinct HIV-1 quasispecies. Drug-resistance mutations were also distributed differently from one cell type to another. This compartmentalization suggests a minimal virus trafficking between blood cell types during suppressive HAART.
We observed a cell-specific compartmentalization of the residual virus populations during prolonged suppressive HAART. The coexistence of numerous HIV-1 quasispecies with different resistance genotypes and coreceptor use in cellular reservoirs may be relevant for future antiretroviral treatment strategies.
HIV-1储存库是病毒根除的主要障碍。因此,有必要清楚地了解在高效抗逆转录病毒疗法(HAART)治疗下血浆病毒血症持续受到抑制的患者体内持续存在的病毒群体的分子特性。
我们对从三名选定的接受HAART治疗7年且病毒载量持续检测不到的患者的高度纯化血细胞类型中分离出的HIV-1准种的基因型进行了详细分析。
在HAART治疗7年后,我们使用多色流式细胞术从外周血单个核细胞中分选初始和记忆性CD4 T细胞、CD14单核细胞以及CD56+CD3-自然杀伤(NK)细胞。采用克隆分析来确定分选的血细胞类型中HIV-1准种的共受体使用情况和耐药基因型。
我们在记忆性和初始CD4 T细胞以及CD14单核细胞中检测到了HIV-1 DNA,但在CD56+CD3- NK细胞中未检测到。系统发育分析表明,三名患者中的两名患者的不同血细胞类型中存在基因上不同的HIV-1准种。耐药突变在不同细胞类型中的分布也有所不同。这种区室化表明在抑制性HAART期间血细胞类型之间的病毒 trafficking 极少。
我们观察到在长期抑制性HAART期间残留病毒群体存在细胞特异性区室化。细胞储存库中存在多种具有不同耐药基因型和共受体使用情况的HIV-1准种,这可能与未来的抗逆转录病毒治疗策略相关。